
|Videos|December 29, 2014
Weighing Cost Vs. Cure in Hepatitis C Treatments
Raulo Frear, PharmD, general manager of OmedaRx, discusses the high initial cost of hepatitis C drugs like Sovaldi compared with the long term cost of treating the disease.
Advertisement
Raulo Frear, PharmD, general manager of OmedaRx, discusses the high initial cost of hepatitis C drugs like Sovaldi compared with the long term cost of treating the disease.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Therapeutic Cancer Vaccines: Are We There Yet?
2
Emerging Biomarkers Open New Frontiers in Lung Cancer Therapy
3
Transforming HER2+ Metastatic Breast Cancer Treatment With Targeted ADC Therapy
4
Weekly Paclitaxel May Hold the Key to Pembrolizumab’s Success in Platinum-Resistance Ovarian Cancer
5